Publication information: “Modulation of lipid nanoparticle-formulated plasmid DNA drives innate immune activation promoting adaptive immunity,” from Cell Reports Medicine ...
Fred Hutch virologist Keith Jerome, MD, PhD, and evolutionary biologist Jesse Bloom, PhD, were recently elected to the 2025 ...
1d
Stockhead on MSNHow shifting to big pharma is paying off for Clever Culture SystemsBiotech Clever Culture Systems has made a significant strategic pivot to target big pharma customers, and it looks like the .
Quickly and accurately identifying which microbe is causing a patient’s disease is key to developing the proper treatment.
Data highlights potential of CD388 as a potent, universal antiviral for influenza prevention regardless of immune statusSAN DIEGO, March 17, ...
Researchers at the National Institutes of Health (NIH) have determined that dermatitis resulting from topical steroid withdrawal (TSW) is distinct from eczema and is caused by an excess of an ...
The firm's Italian distributor A.D.A. is beginning a four-hospital study in collaboration with the Italian Society for Clinical Microbiology to evaluate the system.
My name is John MacSharry, and I lecture medical microbiology at UCC. I am also a member of the APC Microbiome Ireland Research Team and a Research Partner of Atlantia Food and Clinical Trials.
Panelists discuss exciting updates on Bruton tyrosine kinase (BTK) inhibitors from the 2024 American Society of Hematology (ASH) Annual Meeting and Exposition, highlighting emerging data that may ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results